Jubilant Pharmova Limited has informed the Exchange regarding Resignation of Mr. Arun Kumar Sharma as Chief Financial Officer of the company w.e.f. May 22, 2026.
JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova announced the resignation of Mr. Arun Kumar Sharma as Chief Financial Officer effective close of business hours on May 22, 2026. Sharma is not leaving the company entirely—he will transition to the role of Advisor to the Chairmen. Simultaneously, the board approved the appointment of Mr. Ashish Mukkirwar as the new CFO and Key Managerial Personnel (KMP) effective May 23, 2026. Mukkirwar brings over two decades of experience, having previously served as Group Vice President & CFO at Glenmark Pharmaceuticals, with prior roles at Moelis & Company and UBS Investment Banking. He holds an MBA from IIM Kolkata. The transition appears smooth with no gap in leadership.
The CFO changeover is orderly with an experienced external replacement, which should provide continuity for investors. The resignation followed by internal reassignment suggests a planned transition rather than a contentious departure, which is generally positive for governance sentiment.